Osteogenesis imperfecta: Clinical diagnosis, nomenclature.
Osteogenesis imperfecta describes a group of genetic disorders that are colloquially known as “brittle bone disease” and is estimated to affect around 7 out 100,000 people around the world.
Osteogenesis Imperfecta is a rare hereditary disorder that affects the connective tissue and causes extremely brittle bones which are in turn easily broken and deformed. There are multiple subdivisions of the disorder, ranging from Type I, Type II, Type III, and Type IV.
Osteogenesis imperfecta (OI) is a rare genetic disorder that, like juvenile osteoporosis, is characterized by bones that break easily, often from little or no apparent cause. However, OI is caused.
Osteogenesis Imperfecta Research Paper Introduction Osteogenesis imperfecta describes a group of genetic disorders that are colloquially known as “brittle bone disease” and is estimated to affect around 7 out 100,000 people around the world.
Medical research papers related to Osteogenesis imperfecta include: Physical training in children with osteogenesis imperfecta A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management.
I don't wanna write my paper Osteogenesis imperfecta type i research paper.
What is Osteogenesis Imperfecta? OI is a genetic disorder of connective tissue and in addition to bone fragility, can cause sensorineural or conductive hearing loss, scoliosis, decreased pulmonary function, and abnormal dental and craniofacial development.